(Q54227226)

26 May 2018

title

Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status. (English)

1 reference

26 May 2018

1 reference

Jinghui Wang

1

1 reference

26 May 2018

Yujie Dong

2

1 reference

26 May 2018

Yiran Cai

3

1 reference

26 May 2018

Lijuan Zhou

4

1 reference

26 May 2018

Shafei Wu

5

1 reference

26 May 2018

Guimei Liu

6

1 reference

26 May 2018

Dan Su

7

1 reference

26 May 2018

Xi Li

8

1 reference

26 May 2018

Na Qin

9

1 reference

26 May 2018

Jingying Nong

10

1 reference

26 May 2018

Hongyan Jia

11

1 reference

26 May 2018

Quan Zhang

12

1 reference

26 May 2018

Jing Mu

13

1 reference

26 May 2018

Xuan Zeng

14

1 reference

26 May 2018

Haiqing Zhang

15

1 reference

26 May 2018

Shucai Zhang

16

1 reference

26 May 2018

Zongde Zhang

17

1 reference

26 May 2018

publication date

18 January 2014

1 reference

26 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

26 May 2018

volume

140

1 reference

26 May 2018

issue

3

1 reference

26 May 2018

page(s)

453-460

1 reference

26 May 2018

The 2004 World Health Organization classification of lung tumors

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Somatic mutations affect key pathways in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

New driver mutations in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

A mouse model for EML4-ALK-positive lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1584-8

10.1007/S00432-014-1584-8

21 January 2018

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018